The Drugs Controller General of India (DCGI) approved the two vaccines Covaxin and Corbevax for children under 12 in India, against COVID-19. While Bharat Biotech's Covaxin has been approved for 6 to12-year-old, Biological E's Corbevax will be used as Emergency Use Authorization (EUA) for 5 to12-year-old kids in India. The approval was based on the Subject Expert Committee's recommendation report, which was prepared as per trials of the… read-more
Courtesy: The Free Press Journal
The Union Health Ministry has confirmed the availability of over 15.90crore vaccine doses for COVID-19 with states and union territories in India. On April 7, the Centre said, of the total 186.36 crore vaccine were provided of which, over 15 crores are still with States and UTs. It is to be noted, the nationwide vaccine drive started in January 2021, vaccinating the majority of population against the deadly Coronavirus.
The Drugs Controller General of India (DCGI) on January 27, granted regular market approval to India's Covaxin and Covishield vaccines against COVID-19. Following SEC's recommendations, the DCGI allowed only hospitals and clinics to purchase the SII's Covishield and Bharat Biotech's Covaxin under the New Drugs And Clinical Trials 2019 Act. However, the authority needs to submit data every six months to the DCGI and update on CoWIN app.
Courtesy: News 18